The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Oral Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The global Human Oral Vaccine market size is expected to reach US$ 2261.9 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Human Oral Vaccine in various end use industries. The expanding demands from the Child and Aldult, are propelling Human Oral Vaccine market. Rotavirus Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cholera Vaccine segment is estimated at % CAGR for the next seven-year period.
International organizations, such as the World Health Organization (WHO) and UNICEF, have been actively promoting and supporting vaccination programs, which has positively impacted the oral vaccine market.
Oral vaccines have been essential for travel vaccination, especially for diseases like cholera and typhoid, which are prevalent in certain regions.
Continued investment in research and development has led to the discovery of new oral vaccine candidates and improved formulations.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Oral Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Oral Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Oral Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Oral Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Oral Vaccine covered in this report include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc.
The global Human Oral Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Global Human Oral Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Oral Vaccine market, Segment by Type:
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Global Human Oral Vaccine market, by Application
Child
Aldult
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Oral Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Oral Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The global Human Oral Vaccine market size is expected to reach US$ 2261.9 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Human Oral Vaccine in various end use industries. The expanding demands from the Child and Aldult, are propelling Human Oral Vaccine market. Rotavirus Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cholera Vaccine segment is estimated at % CAGR for the next seven-year period.
International organizations, such as the World Health Organization (WHO) and UNICEF, have been actively promoting and supporting vaccination programs, which has positively impacted the oral vaccine market.
Oral vaccines have been essential for travel vaccination, especially for diseases like cholera and typhoid, which are prevalent in certain regions.
Continued investment in research and development has led to the discovery of new oral vaccine candidates and improved formulations.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Oral Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Oral Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Oral Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Oral Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Oral Vaccine covered in this report include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc.
The global Human Oral Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Global Human Oral Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Oral Vaccine market, Segment by Type:
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Global Human Oral Vaccine market, by Application
Child
Aldult
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Oral Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Oral Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Human Oral Vaccine Market Overview
1.1 Human Oral Vaccine Product Overview
1.2 Human Oral Vaccine Market Segment by Type
1.2.1 Rotavirus Vaccine
1.2.2 Cholera Vaccine
1.2.3 Oral Polio Vaccine
1.2.4 Other
1.3 Global Human Oral Vaccine Market Size by Type
1.3.1 Global Human Oral Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Human Oral Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Oral Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Oral Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Oral Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Oral Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Oral Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Oral Vaccine Sales Breakdown by Type (2018-2023)
2 Global Human Oral Vaccine Market Competition by Company
2.1 Global Top Players by Human Oral Vaccine Sales (2018-2023)
2.2 Global Top Players by Human Oral Vaccine Revenue (2018-2023)
2.3 Global Top Players by Human Oral Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Human Oral Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Oral Vaccine Market Competitive Situation and Trends
2.5.1 Human Oral Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Oral Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Oral Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Human Oral Vaccine Market
2.8 Key Manufacturers Human Oral Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Oral Vaccine Status and Outlook by Region
3.1 Global Human Oral Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Oral Vaccine Historic Market Size by Region
3.2.1 Global Human Oral Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Human Oral Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Human Oral Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Oral Vaccine Forecasted Market Size by Region
3.3.1 Global Human Oral Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Human Oral Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Human Oral Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Oral Vaccine by Application
4.1 Human Oral Vaccine Market Segment by Application
4.1.1 Child
4.1.2 Aldult
4.2 Global Human Oral Vaccine Market Size by Application
4.2.1 Global Human Oral Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Human Oral Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Oral Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Oral Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Oral Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Oral Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Oral Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Oral Vaccine Sales Breakdown by Application (2018-2023)
5 North America Human Oral Vaccine by Country
5.1 North America Human Oral Vaccine Historic Market Size by Country
5.1.1 North America Human Oral Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Oral Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Human Oral Vaccine Sales in Value by Country (2018-2023)
5.2 North America Human Oral Vaccine Forecasted Market Size by Country
5.2.1 North America Human Oral Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Human Oral Vaccine Sales in Value by Country (2024-2029)
6 Europe Human Oral Vaccine by Country
6.1 Europe Human Oral Vaccine Historic Market Size by Country
6.1.1 Europe Human Oral Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Oral Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Oral Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Human Oral Vaccine Forecasted Market Size by Country
6.2.1 Europe Human Oral Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Oral Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Oral Vaccine by Region
7.1 Asia-Pacific Human Oral Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Human Oral Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Oral Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Oral Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Oral Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Oral Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Oral Vaccine Sales in Value by Region (2024-2029)
8 Latin America Human Oral Vaccine by Country
8.1 Latin America Human Oral Vaccine Historic Market Size by Country
8.1.1 Latin America Human Oral Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Oral Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Oral Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Human Oral Vaccine Forecasted Market Size by Country
8.2.1 Latin America Human Oral Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Oral Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Oral Vaccine by Country
9.1 Middle East and Africa Human Oral Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Human Oral Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Oral Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Oral Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Oral Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Oral Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Oral Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Human Oral Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Human Oral Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi Human Oral Vaccine Products Offered
10.3.5 Sanofi Recent Development
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Company Information
10.4.2 Lanzhou Institute Introduction and Business Overview
10.4.3 Lanzhou Institute Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Lanzhou Institute Human Oral Vaccine Products Offered
10.4.5 Lanzhou Institute Recent Development
10.5 Serum Institute
10.5.1 Serum Institute Company Information
10.5.2 Serum Institute Introduction and Business Overview
10.5.3 Serum Institute Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Serum Institute Human Oral Vaccine Products Offered
10.5.5 Serum Institute Recent Development
10.6 Valneva
10.6.1 Valneva Company Information
10.6.2 Valneva Introduction and Business Overview
10.6.3 Valneva Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Valneva Human Oral Vaccine Products Offered
10.6.5 Valneva Recent Development
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Company Information
10.7.2 Shanghai United Cell Introduction and Business Overview
10.7.3 Shanghai United Cell Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Shanghai United Cell Human Oral Vaccine Products Offered
10.7.5 Shanghai United Cell Recent Development
10.8 Bibcol
10.8.1 Bibcol Company Information
10.8.2 Bibcol Introduction and Business Overview
10.8.3 Bibcol Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bibcol Human Oral Vaccine Products Offered
10.8.5 Bibcol Recent Development
10.9 PaxVax
10.9.1 PaxVax Company Information
10.9.2 PaxVax Introduction and Business Overview
10.9.3 PaxVax Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 PaxVax Human Oral Vaccine Products Offered
10.9.5 PaxVax Recent Development
10.10 Vabiotech
10.10.1 Vabiotech Company Information
10.10.2 Vabiotech Introduction and Business Overview
10.10.3 Vabiotech Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Vabiotech Human Oral Vaccine Products Offered
10.10.5 Vabiotech Recent Development
10.11 Tiantan Biological
10.11.1 Tiantan Biological Company Information
10.11.2 Tiantan Biological Introduction and Business Overview
10.11.3 Tiantan Biological Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Tiantan Biological Human Oral Vaccine Products Offered
10.11.5 Tiantan Biological Recent Development
10.12 EuBiologics
10.12.1 EuBiologics Company Information
10.12.2 EuBiologics Introduction and Business Overview
10.12.3 EuBiologics Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 EuBiologics Human Oral Vaccine Products Offered
10.12.5 EuBiologics Recent Development
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Company Information
10.13.2 Panacea Biotec Ltd Introduction and Business Overview
10.13.3 Panacea Biotec Ltd Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Panacea Biotec Ltd Human Oral Vaccine Products Offered
10.13.5 Panacea Biotec Ltd Recent Development
10.14 Bio-Med
10.14.1 Bio-Med Company Information
10.14.2 Bio-Med Introduction and Business Overview
10.14.3 Bio-Med Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Bio-Med Human Oral Vaccine Products Offered
10.14.5 Bio-Med Recent Development
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Company Information
10.15.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview
10.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Products Offered
10.15.5 Halfkin Bio-Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Oral Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Oral Vaccine Industrial Chain Analysis
11.4 Human Oral Vaccine Market Dynamics
11.4.1 Human Oral Vaccine Industry Trends
11.4.2 Human Oral Vaccine Market Drivers
11.4.3 Human Oral Vaccine Market Challenges
11.4.4 Human Oral Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Oral Vaccine Distributors
12.3 Human Oral Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
